Novel cb 1 receptor inverse agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/04 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61K 31/497 (2006.01) A61K 31/506 (2006.01) A61P 3/04 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2511905

The present invention relates to compounds of formula (1) wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CBI receptors.

L'invention concerne des composés de formule générale (I), dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿ et R?7¿ ont la signification indiquée dans la description et les revendications, et des sels acceptables sur le plan pharmaceutique de ceux-ci. Ces composés sont utiles pour le traitement et/ou la prophylaxie de maladies associées à la modulation des récepteurs CB1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel cb 1 receptor inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel cb 1 receptor inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cb 1 receptor inverse agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1444758

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.